Midwestern University’s College of Dental Medicine-Illinois has been awarded an $8,000 grant by the Illinois State Dental ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical ...

The Orphan Drug designation is supported by positive preclinical data from bleomycin-induced mouse models and patient-derived skin fibroblasts.

Study found OV329 cleared and remained undetectable in the retina, eye, and brain tissues of mice, unlike vigabatrin which ...

The Company is also pleased to announce the closing of the first tranche of the Offering for gross proceeds of $1,610,147.55 from the issuance of 2,927,541 Units. All securities issued pursuant to the ...

ATCC will provide a broad range of in vivo and in vitro models, as well as specialized reagents, for use in infectious ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

Crohn's disease -; an autoimmune disorder -; is characterized by chronic inflammation of the digestive tract, resulting in a slew of debilitating gastrointestinal symptoms that vary from patient to ...

RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality.

In the newly published study, voriconazole dry powder formulations for inhalation were prepared by three different methods: jet-milling, spray-drying, and Thin Film Freezing. The TFF processed ...

Finnish pharmaceutical company Orion has entered a partnership with Aitia to leverage artificial intelligence in drug ...